Policy Notices

• Updated Process for Requesting Drawdowns Outside of the Liquidation Period
  (NOT-OD-23-086)
  National Institutes of Health
  

General Notices

• Request for Information on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research
  (NOT-OD-23-091)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine" NOT-AI-23-007
  (NOT-AI-23-030)
  National Institute of Allergy and Infectious Diseases
  

• Notice of NIGMS Withdrawal of Participation from PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
  (NOT-GM-23-032)
  National Institute of General Medical Sciences
  

• Notice of NIGMS Withdrawal of Participation from PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
  (NOT-GM-23-033)
  National Institute of General Medical Sciences
  

• Notice of Participation of the National Human Genome Research Institute (NHGRI) in PA-20-163: Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
  (NOT-HG-23-021)
  National Human Genome Research Institute
  

• Notice of Participation of NIMH in PAR-20-315, "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)"
  (NOT-MH-23-220)
  National Institute of Mental Health
  

• Notice of NIMH Withdrawal from Participation in PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)"
  (NOT-MH-23-225)
  National Institute of Mental Health
  

• Notice of Clarification Regarding Eligibility Information for SBIR/STTR Commercialization Readiness Pilot Program (CRP)
  (NOT-OD-23-087)
  Office of the Director, NIH
  

• Notice of Change to Minimum Performance Standards for SBIR and STTR Applicants
  (NOT-OD-23-092)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
  (NOT-NS-23-068)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
  (NOT-NS-23-069)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute of Mental Health
  

Requests for Proposal

• Pre-Solicitation Notice: Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA), RFP: 75N93022R00017
  (NOT-AI-23-034)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
  (NOT-AI-23-031)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplement to Support Health Policy Research in Cancer Prevention and Control
  (NOT-CA-23-044)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative supplements to conduct systematic evidence reviews on the clinical utility of cancer-site specific polygenic risk scores (PRS) for cancer risk assessment
  (NOT-CA-23-046)
  National Cancer Institute
  

• Notice of Special Interest (NOSI) in Applications to Support Training, Workforce Development, and Diversity Conferences (R13)
  (NOT-GM-23-028)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy
  (NOT-HL-23-080)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): Research supplements to promote workforce diversity and enhance utility and use of Common Fund datasets
  (NOT-RM-23-005)
  Office of Strategic Coordination (Common Fund)
  National Human Genome Research Institute
  

Funding Opportunities

• Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
  (RFA-AI-23-015)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 02, 2023
  
  

• Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed)
  (RFA-DA-24-008)
  National Institute on Drug Abuse
  National Library of Medicine
  Application Receipt Date(s): August 10, 2023
  
  

• Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed)
  (RFA-DA-24-009)
  National Institute on Drug Abuse
  National Library of Medicine
  Application Receipt Date(s): August 10, 2023
  
  

• Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional
  (RFA-FD-23-028)
  Food and Drug Administration
  Application Receipt Date(s): May 04, 2023
  
  

• NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
  (RFA-OH-23-005)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): September 29, 2024